Want to join the conversation?
In 3Q15, $ICPT announced the initiation of its REGENERATE Phase 3 trial, this is the first phase Phase 3 registrational trial in non-cirrhotic NASH patients with fibrosis, a serious chronic liver disease with no approved therapies. $ICPT is targeting enrollment of 1,400 biopsy-proven NASH patients with stage 2 and stage 3 fibrosis.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.